Huepenbecker Sarah P, Iniesta Maria D, Wang Xin S, Cain Katherine E, Zorrilla-Vaca Andres, Shen Shu-En, Basabe M Sol, Suki Tina, Garcia Lopez Juan E, Mena Gabriel E, Lasala Javier D, Williams Loretta A, Ramirez Pedro T, Meyer Larissa A
Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.
Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, TX.
Am J Obstet Gynecol. 2024 Feb;230(2):241.e1-241.e18. doi: 10.1016/j.ajog.2023.10.012. Epub 2023 Oct 11.
There are few prospective studies in the gynecologic surgical literature that compared patient-reported outcomes between open and minimally invasive hysterectomies within enhanced recovery after surgery pathways.
This study aimed to compare prospectively collected perioperative patient-reported symptom burden and interference measures in open compared with minimally invasive hysterectomy cohorts within enhanced recovery after surgery pathways.
We compared patient-reported symptom burden and functional interference in 646 patients who underwent a hysterectomy (254 underwent open surgery and 392 underwent minimally invasive surgery) for benign and malignant indications under enhanced recovery after surgery protocols. Outcomes were prospectively measured using the validated MD Anderson Symptom Inventory, which was administered perioperatively up to 8 weeks after surgery. Cohorts were compared using Fisher exact and chi-squared tests, adjusted longitudinal generalized linear mixed modeling, and Kaplan Meier curves to model return to no or mild symptoms.
The open cohort had significantly worse preoperative physical functional interference (P=.001). At the time of hospital discharge postoperatively, the open cohort reported significantly higher mean symptom severity scores and more moderate or severe scores for overall (P<.001) and abdominal pain (P<.001), fatigue (P=.001), lack of appetite (P<.001), bloating (P=.041), and constipation (P<.001) when compared with the minimally invasive cohort. The open cohort also had significantly higher interference in physical functioning (score 5.0 vs 2.7; P<.001) than the minimally invasive cohort at the time of discharge with no differences in affective interference between the 2 groups. In mixed modeling analysis of the first 7 postoperative days, both cohorts reported improved symptom burden and functional interference over time with generally slower recovery in the open cohort. From 1 to 8 postoperative weeks, the open cohort had worse mean scores for all evaluated symptoms and interference measures except for pain with urination, although scores indicated mild symptomatic burden and interference in both cohorts. The time to return to no or mild symptoms was significantly longer in the open cohort for overall pain (14 vs 4 days; P<.001), fatigue (8 vs 4 days; P<.001), disturbed sleep (2 vs 2 days; P<.001), and appetite (1.5 vs 1 days; P<.001) but was significantly longer in the minimally invasive cohort for abdominal pain (42 vs 28 days; P<.001) and bloating (42 vs 8 days; P<.001). The median time to return to no or mild functional interference was longer in the open than in the minimally invasive hysterectomy cohort for physical functioning (36 vs 32 days; P<.001) with no difference in compositive affective functioning (5 vs 5 days; P=.07) between the groups.
Open hysterectomy was associated with increased symptom burden in the immediate postoperative period and longer time to return to no or mild symptom burden and interference with physical functioning. However, all patient-reported measures improved within days to weeks of both open and minimally invasive surgery and differences were not always clinically significant.
在妇科手术文献中,很少有前瞻性研究比较在手术加速康复路径下,开腹子宫切除术和微创子宫切除术患者报告的结局。
本研究旨在前瞻性比较在手术加速康复路径下,开腹子宫切除术与微创子宫切除术队列中围手术期患者报告的症状负担和干扰指标。
我们比较了646例行子宫切除术患者(254例行开腹手术,392例行微创手术)在手术加速康复方案下,因良性和恶性指征导致的患者报告的症状负担和功能干扰。使用经过验证的MD安德森症状量表前瞻性测量结局,该量表在围手术期直至术后8周进行管理。使用Fisher精确检验和卡方检验、调整后的纵向广义线性混合模型以及Kaplan Meier曲线对队列进行比较,以模拟恢复至无症状或轻度症状的情况。
开腹手术队列术前身体功能干扰明显更严重(P = 0.001)。术后出院时,与微创队列相比,开腹队列报告的总体(P < 0.001)、腹痛(P < 0.001)、疲劳(P = 0.001)、食欲不振(P < 0.001)、腹胀(P = 0.041)和便秘(P < 0.001)的平均症状严重程度得分显著更高,且中度或重度得分更多。出院时,开腹队列的身体功能干扰也明显高于微创队列(得分5.0对2.7;P < 0.001),两组间情感干扰无差异。在术后前7天的混合模型分析中,两个队列的症状负担和功能干扰均随时间改善,但开腹队列恢复通常较慢。术后1至8周,除排尿疼痛外,开腹队列所有评估症状和干扰指标的平均得分均较差,尽管两组得分均表明症状负担和干扰较轻。开腹队列总体疼痛(14天对4天;P < 0.001)、疲劳(8天对4天;P < 0.001)、睡眠障碍(2天对2天;P < 0.001)和食欲(1.5天对1天;P < 0.001)恢复至无症状或轻度症状的时间明显更长,但微创队列腹痛(42天对28天;P < 0.001)和腹胀(42天对8天;P < 0.001)恢复时间明显更长。开腹子宫切除术队列恢复至无症状或轻度功能干扰的中位时间长于微创子宫切除术队列(36天对32天;P < 0.001),两组间综合情感功能无差异(5天对5天;P = 0.07)。
开腹子宫切除术与术后即刻症状负担增加以及恢复至无症状或轻度症状负担和身体功能干扰的时间延长相关。然而,所有患者报告的指标在开腹手术和微创手术后的数天至数周内均有所改善,且差异并非总是具有临床意义。